Addus HomeCare Corp ADUS Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0000950170-25-064522
cik 1468328
name ADDUS HOMECARE CORP
sic 8082
countryba US
stprba TX
cityba FRISCO
zipba 75034
bas1 6303 COWBOYS WAY
bas2 SUITE 600
baph 469-535-8200
countryma US
stprma TX
cityma FRISCO
zipma 75034
mas1 6303 COWBOYS WAY
mas2 SUITE 600
countryinc US
stprinc DE
ein 205340172
former
changed
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250506
accepted 2025-05-06 16:30:00.0
prevrpt 0
detail 1
instance adus-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0000950170-25-064522 20241231 Accrued Liabilities Current 28959000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Accrued Salaries Current 62053000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Amortization Of Financing Costs 215000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Common Stock Shares Issued 18399000.0000 shares 0 us-gaap/2024
0000950170-25-064522 20250331 Common Stock Value 18000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Deferred Income Tax Expense Benefit 131000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Earnings Per Share Diluted 1.1600 USD 1 us-gaap/2024
0000950170-25-064522 20241231 Goodwill 970558000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Goodwill 95192000.0000 USD 0 us-gaap/2024 Business Segments= Home Health;
0000950170-25-064522 20250331 Government Assistance Liability Current 8702000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Income Tax Expense Benefit 5770000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Increase Decrease In Other Accounts Payable And Accrued Liabilities 1158000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Liabilities 412201000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Net Cash Provided By Used In Investing Activities -1378000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Net Income Loss 21228000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064522 20241231 Other Assets 1127549000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Payments To Acquire Businesses Net Of Cash Acquired 3350000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Payments To Acquire Property Plant And Equipment 1350000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240531 Proceeds From Divestiture Of Businesses 4600000.0000 USD 0 us-gaap/2024 Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations= New York Disposition Treatment;
0000950170-25-064522 20241231 Property Plant And Equipment Net 24703000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 26000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= State Local And Other Governmental Programs Excluding Medicare;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 208003000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 337708000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 17985000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 8555000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= N M;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 7913000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= N M;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 1160000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Commercial Insurance;
0000950170-25-064522 20240331 Share Based Compensation 2619000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20231231 Stockholders Equity 706694000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20231231 Stockholders Equity 403846000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064522 20240331 Stockholders Equity 16000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20241231 Stockholders Equity 376430000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064522 20250331 Stockholders Equity 597707000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064522 20250331 Stockholders Equity 397658000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064522 20250331 Weighted Average Number Of Shares Outstanding Basic 17976000.0000 shares 1 us-gaap/2024
0000950170-25-064522 20241231 Workers Compensation Liability Current 13644000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Assets 1412634000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Accounts Payable Current 27176000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Accounts Payable Current 27969000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Additional Paid In Capital Common Stock 594044000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 11928000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Common Stock Shares Issued 18148000.0000 shares 0 us-gaap/2024
0000950170-25-064522 20241231 Common Stock Value 18000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Depreciation Depletion And Amortization 3943000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Earnings Per Share Basic 1.1800 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Gain Loss On Disposition Of Assets 7000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Goodwill 972347000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Goodwill 444462000.0000 USD 0 us-gaap/2024 Business Segments= Personal Care;
0000950170-25-064522 20241231 Government Assistance Liability Current 11239000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 21310000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 26998000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20240331 Income Taxes Paid Net 13000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Increase Decrease In Accounts Payable -588000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Increase Decrease In Accounts Receivable 9459000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -9331000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Intangible Assets Net Excluding Goodwill 4200000.0000 USD 0 us-gaap/2024 Disposal Group Classification= Disposal Group Disposed Of By Sale Not Discontinued Operations;
0000950170-25-064522 20250331 Interest Expense Debt 4018000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Investment Income Interest 502000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20241231 Liabilities 442142000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Long Term Debt Noncurrent 198740000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Net Income Loss 21228000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 55863000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 7515000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= N M;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 1087000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= State Local And Other Governmental Programs Excluding Medicare;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 7498000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= T N;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 258286000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 273000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= N Y;
0000950170-25-064522 20250331 Stock Issued During Period Shares Stock Options Exercised 25000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20250331 Gain Loss On Termination Of Lease -23000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Accounts Receivable Net Current 134607000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Accrued Salaries Current 54858000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 2619000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Assets 1407584000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Assets Current 260382000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Assets Current 257828000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 98911000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Goodwill 800000.0000 USD 0 us-gaap/2024 Business Acquisition= Jacksonville Affiliate; Business Segments= Personal Care;
0000950170-25-064522 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 96954000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Common Stock Shares Authorized 40000000.0000 shares 0 us-gaap/2024
0000950170-25-064522 20240331 Depreciation And Amortization 3469000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Goodwill 2600000.0000 USD 0 us-gaap/2024 Business Acquisition= Great Lakes Home Care Unlimited L L C; Business Segments= Personal Care;
0000950170-25-064522 20250331 Goodwill 95045000.0000 USD 0 us-gaap/2024 Business Segments= Home Health;
0000950170-25-064522 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 21310000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20240331 Income Tax Expense Benefit 5480000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets -8323000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20241231 Intangible Assets Net Excluding Goodwill 109643000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Interest Paid Net 3743000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Liabilities Current 147936000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Liabilities Noncurrent 286271000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Operating Expenses 77163000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Operating Income Loss 23645000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Operating Income Loss 1277000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Consolidation Items= Operating Segments;
0000950170-25-064522 20240331 Operating Income Loss 13457000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Operating Income Loss 3014000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Operating Lease Liability Current 12649000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Operating Lease Liability Noncurrent 41883000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Operating Lease Liability Noncurrent 39414000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Payments To Acquire Property Plant And Equipment 1883000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20241231 Prepaid Expense And Other Assets Current 38591000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Property Plant And Equipment Net 24701000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Repayments Of Lines Of Credit 25000000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 7777000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= N M;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 208003000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 28967000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= N M;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 238000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Other;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 61437000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 14564000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= I L;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 239000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Other;
0000950170-25-064522 20240331 Shares Outstanding 16370000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20241231 Shares Outstanding 18148000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20250331 Shares Outstanding 18399000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20241231 Stockholders Equity 594044000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064522 20240331 Weighted Average Number Of Diluted Shares Outstanding 16373000.0000 shares 1 us-gaap/2024
0000950170-25-064522 20250331 Workers Compensation Liability Current 14010000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Additional Paid In Capital Common Stock 597707000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 3170000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 3170000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064522 20250331 Cash And Cash Equivalents At Carrying Value 96954000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Common Stock Shares Outstanding 18399000.0000 shares 0 us-gaap/2024
0000950170-25-064522 20250331 Cost Of Goods And Services Sold 230031000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Depreciation And Amortization 3943000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20240331 Depreciation Depletion And Amortization 3469000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Increase Decrease In Employee Related Liabilities -7124000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Interest Income Expense Nonoperating Net -3516000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Investment Income Interest 423000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Investment Income Interest 423000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20240331 Operating Expenses 64532000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Operating Income Loss 40022000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Consolidation Items= Operating Segments;
0000950170-25-064522 20241231 Operating Lease Right Of Use Asset 47348000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Payments To Acquire Businesses Net Of Cash Acquired 400000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Prepaid Expense And Other Assets Current 26267000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Proceeds From Divestiture Of Businesses 3848000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 4400000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Managed Care Organizations;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 2942000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= I L;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 1486000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Commercial Insurance;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 3906000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Private Pay;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 47927000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= All Other States;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 208003000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 3810000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Managed Care Organizations;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 12576000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Medicare;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 512000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Other;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 17985000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 61437000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Consolidation Items= Operating Segments;
0000950170-25-064522 20231231 Stockholders Equity 16000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20240331 Stockholders Equity 725143000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Stockholders Equity 18000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20250331 Stock Issued During Period Shares Restricted Stock Award Gross 227000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20250331 Other Assets 1125055000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Other Liabilities Noncurrent 125000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Accounts Receivable Net Current 122880000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Common Stock Shares Outstanding 18148000.0000 shares 0 us-gaap/2024
0000950170-25-064522 20240331 Earnings Per Share Basic 0.9900 USD 1 us-gaap/2024
0000950170-25-064522 20250331 General And Administrative Expense 73220000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Goodwill 432840000.0000 USD 0 us-gaap/2024 Business Segments= Hospice;
0000950170-25-064522 20240331 Increase Decrease In Accounts Payable -4332000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Interest Expense Debt 2758000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Investment Income Interest 502000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Liabilities Noncurrent 264265000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Net Cash Provided By Used In Financing Activities -25000000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Net Income Loss 15830000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064522 20250331 Operating Income Loss 30514000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Operating Income Loss 14617000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Operating Income Loss 65223000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20241231 Operating Lease Liability Current 12800000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Operating Lease Right Of Use Asset 45064000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Repayments Of Lines Of Credit 20000000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 16880000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 791000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Other;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 3134000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Commercial Insurance;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 1817000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Managed Care Organizations;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 15860000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= All Other States;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 20236000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= O H;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 94276000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Managed Care Organizations;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 107754000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= State Local And Other Governmental Programs;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 107575000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= I L;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 1932000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= I L;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 56788000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Medicare;
0000950170-25-064522 20240331 Stockholders Equity 318662000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064522 20240331 Stock Issued During Period Shares Restricted Stock Award Gross 143000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20250331 Weighted Average Number Of Diluted Shares Outstanding 18311000.0000 shares 1 us-gaap/2024
0000950170-25-064522 20240331 Weighted Average Number Of Shares Outstanding Basic 16063000.0000 shares 1 us-gaap/2024
0000950170-25-064522 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 64791000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 76719000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -1957000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20241231 Common Stock Shares Authorized 40000000.0000 shares 0 us-gaap/2024
0000950170-25-064522 20240331 Cost Of Goods And Services Sold 192569000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20241231 Deferred Income Tax Liabilities Net 25820000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Depreciation And Amortization 3469000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Goodwill 2900000.0000 USD 0 us-gaap/2024 Disposal Group Classification= Disposal Group Disposed Of By Sale Not Discontinued Operations;
0000950170-25-064522 20250331 Gross Profit 107677000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Income Taxes Paid Net -11000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Increase Decrease In Accounts Receivable -10552000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Intangible Assets Net Excluding Goodwill 107644000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Net Cash Provided By Used In Financing Activities -19528000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Net Cash Provided By Used In Investing Activities -1750000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Operating Income Loss 47592000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Consolidation Items= Operating Segments;
0000950170-25-064522 20241231 Other Liabilities Noncurrent 125000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Payments Of Debt Issuance Costs 21000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Profit Loss 15830000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Profit Loss 21228000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Provision For Doubtful Accounts 224000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 280746000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 16880000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 50652000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Medicare;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 23534000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= N Y;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 2383000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Commercial Insurance;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 2028000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Managed Care Organizations;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 117007000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Managed Care Organizations;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 68433000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= All Other States;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 28305000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= N M;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 49861000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= T X;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 258286000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Share Based Compensation 3170000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20231231 Stockholders Equity 302832000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-064522 20250331 Stockholders Equity 995383000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Amortization Of Financing Costs 318000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Depreciation And Amortization 3943000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Earnings Per Share Diluted 0.9700 USD 1 us-gaap/2024
0000950170-25-064522 20241231 Goodwill 432840000.0000 USD 0 us-gaap/2024 Business Segments= Hospice;
0000950170-25-064522 20241231 Goodwill 442526000.0000 USD 0 us-gaap/2024 Business Segments= Personal Care;
0000950170-25-064522 20240331 Increase Decrease In Other Accounts Payable And Accrued Liabilities 5385000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Interest Income Expense Nonoperating Net -2335000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Interest Paid Net 2527000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20241231 Liabilities Current 155871000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Net Cash Provided By Used In Operating Activities 38678000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Net Cash Provided By Used In Operating Activities 18949000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Net Income Loss 15830000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Provision For Doubtful Accounts 335000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Proceeds From Sale Of Machinery And Equipment 7000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Proceeds From Stock Options Exercised 493000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 11663000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Medicare;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 12252000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= I L;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 55863000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Consolidation Items= Operating Segments;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 280746000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 17985000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 61437000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 23187000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= O H;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 258286000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 6976000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Private Pay;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 111414000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= I L;
0000950170-25-064522 20231231 Shares Outstanding 16227000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20240331 Stockholders Equity 406465000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064522 20250331 Stock Issued During Period Value Stock Options Exercised 493000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Stock Issued During Period Value Stock Options Exercised 493000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064522 20250331 Accrued Liabilities Current 29748000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 2619000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-064522 20241231 Cash And Cash Equivalents At Carrying Value 98911000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Deferred Income Tax Expense Benefit 166000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Deferred Income Tax Liabilities Net 25986000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 General And Administrative Expense 61063000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Gross Profit 88177000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 26998000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Increase Decrease In Employee Related Liabilities -12529000.0000 USD 1 us-gaap/2024
0000950170-25-064522 20240331 Increase Decrease In Government Stimulus Advances 7783000.0000 USD 1 0000950170-25-064522
0000950170-25-064522 20250331 Increase Decrease In Government Stimulus Advances -2537000.0000 USD 1 0000950170-25-064522
0000950170-25-064522 20240331 Interest Expense Debt 2758000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Interest Expense Debt 4018000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20241231 Liabilities And Stockholders Equity 1412634000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Liabilities And Stockholders Equity 1407584000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20241231 Long Term Debt Noncurrent 218443000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Operating Income Loss 54756000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20250331 Proceeds From Divestiture Of Businesses 3800000.0000 USD 1 us-gaap/2024 Disposal Group Classification= Deferred Payments; Type Of Arrangement= Asset Purchase Agreement;
0000950170-25-064522 20241231 Retained Earnings Accumulated Deficit 376430000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Retained Earnings Accumulated Deficit 397658000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 6161000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= T N;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 16880000.0000 USD 1 us-gaap/2024 Business Segments= Home Health; Consolidation Items= Operating Segments;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 55863000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 260000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Other;
0000950170-25-064522 20240331 Revenue From Contract With Customer Excluding Assessed Tax 581000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= Other;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 15773000.0000 USD 1 us-gaap/2024 Business Segments= Hospice; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Geographic Concentration Risk; Geographical= All Other States;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 132904000.0000 USD 1 us-gaap/2024 Business Segments= Personal Care; Concentration Risk By Benchmark= Sales Revenue Net; Concentration Risk By Type= Customer Concentration Risk; Health Care Organization Revenue Sources= State Local And Other Governmental Programs;
0000950170-25-064522 20250331 Revenue From Contract With Customer Excluding Assessed Tax 337708000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000950170-25-064522 20241231 Stockholders Equity 970492000.0000 USD 0 us-gaap/2024
0000950170-25-064522 20250331 Stockholders Equity 18000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-064522 20250331 Stock Issued During Period Shares Restricted Stock Award Forfeited 1000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Stock Issued During Period Value Stock Options Exercised us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Depreciation And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization, Nonproduction The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2024 0 0 monetary D C Payments to Acquire Businesses, Net of Cash Acquired The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Proceeds From Sale Of Machinery And Equipment us-gaap/2024 0 0 monetary D D Proceeds from Sale of Machinery and Equipment The cash inflow from sale of machinery and equipment.
Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
Accrued Salaries Current us-gaap/2024 0 0 monetary I C Accrued Salaries, Current Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Interest Income Expense Nonoperating Net us-gaap/2024 0 0 monetary D C Interest Income (Expense), Nonoperating Amount of interest income (expense) classified as nonoperating.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Proceeds From Stock Options Exercised us-gaap/2024 0 0 monetary D D Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Government Assistance Liability Current us-gaap/2024 0 0 monetary I C Government Assistance, Liability, Current Amount of liability from government assistance, classified as current.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Payments Of Debt Issuance Costs us-gaap/2024 0 0 monetary D C Payments of Debt Issuance Costs The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Cost Of Goods And Services Sold us-gaap/2024 0 0 monetary D D Cost of Goods and Services Sold The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Increase Decrease In Other Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Workers Compensation Liability Current us-gaap/2024 0 0 monetary I C Workers' Compensation Liability, Current Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Employee Related Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Employee Related Liabilities The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Interest Expense Debt us-gaap/2024 0 0 monetary D D Interest Expense, Debt Amount of the cost of borrowed funds accounted for as interest expense for debt.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Stock Issued During Period Shares Restricted Stock Award Forfeited us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Restricted Stock Award, Forfeited Number of shares related to Restricted Stock Award forfeited during the period.
Deferred Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Goodwill us-gaap/2024 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Intangible Assets Net Excluding Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Liabilities, Noncurrent Amount of obligation due after one year or beyond the normal operating cycle, if longer.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Other Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Amortization Of Financing Costs us-gaap/2024 0 0 monetary D D Amortization of Debt Issuance Costs Amount of amortization expense attributable to debt issuance costs.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Proceeds From Divestiture Of Businesses us-gaap/2024 0 0 monetary D D Proceeds from Divestiture of Businesses The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Additional Paid In Capital Common Stock us-gaap/2024 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Deferred Income Tax Liabilities Net us-gaap/2024 0 0 monetary I C Deferred Income Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Gain Loss On Disposition Of Assets us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.
Gain Loss On Termination Of Lease us-gaap/2024 0 0 monetary D C Gain (Loss) on Termination of Lease Amount of gain (loss) on termination of lease before expiration of lease term.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Increase Decrease In Government Stimulus Advances 0000950170-25-064522 1 0 monetary D D Increase Decrease In Government Stimulus Advances Increase decrease in government stimulus advances.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Investment Income Interest us-gaap/2024 0 0 monetary D C Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Repayments Of Lines Of Credit us-gaap/2024 0 0 monetary D C Repayments of Lines of Credit Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Long Term Debt Noncurrent us-gaap/2024 0 0 monetary I C Long-Term Debt, Excluding Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Other Assets us-gaap/2024 0 0 monetary I D Other Assets Amount of assets classified as other.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Provision For Doubtful Accounts us-gaap/2024 0 0 monetary D D Accounts Receivable, Credit Loss Expense (Reversal) Amount of expense (reversal of expense) for expected credit loss on accounts receivable.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0000950170-25-064522 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash 0
0000950170-25-064522 2 4 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net of allowances 0
0000950170-25-064522 2 5 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0000950170-25-064522 2 6 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0000950170-25-064522 2 7 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net of accumulated depreciation and amortization 0
0000950170-25-064522 2 9 BS 0 H Goodwill us-gaap/2024 Goodwill 0
0000950170-25-064522 2 10 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2024 Intangibles, net of accumulated amortization 0
0000950170-25-064522 2 11 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease assets, net 0
0000950170-25-064522 2 12 BS 0 H Other Assets us-gaap/2024 Total other assets 0
0000950170-25-064522 2 13 BS 0 H Assets us-gaap/2024 Total assets 0
0000950170-25-064522 2 16 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0000950170-25-064522 2 17 BS 0 H Accrued Salaries Current us-gaap/2024 Accrued payroll 0
0000950170-25-064522 2 18 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued expenses 0
0000950170-25-064522 2 19 BS 0 H Operating Lease Liability Current us-gaap/2024 Operating lease liabilities, current portion 0
0000950170-25-064522 2 20 BS 0 H Government Assistance Liability Current us-gaap/2024 Government stimulus advances 0
0000950170-25-064522 2 21 BS 0 H Workers Compensation Liability Current us-gaap/2024 Accrued workers' compensation insurance 0
0000950170-25-064522 2 22 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0000950170-25-064522 2 24 BS 0 H Long Term Debt Noncurrent us-gaap/2024 Long-term debt, less current portion, net of debt issuance costs 0
0000950170-25-064522 2 25 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Long-term operating lease liabilities 0
0000950170-25-064522 2 26 BS 0 H Deferred Income Tax Liabilities Net us-gaap/2024 Deferred income tax 0
0000950170-25-064522 2 27 BS 0 H Other Liabilities Noncurrent us-gaap/2024 Other long-term liabilities 0
0000950170-25-064522 2 28 BS 0 H Liabilities Noncurrent us-gaap/2024 Total long-term liabilities 0
0000950170-25-064522 2 29 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0000950170-25-064522 2 31 BS 0 H Common Stock Value us-gaap/2024 Common stock-$.001 par value; 40,000 authorized and 18,399 and 18,148 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 0
0000950170-25-064522 2 32 BS 0 H Additional Paid In Capital Common Stock us-gaap/2024 Additional paid-in capital 0
0000950170-25-064522 2 33 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Retained earnings 0
0000950170-25-064522 2 34 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders' equity 0
0000950170-25-064522 2 35 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' equity 0
0000950170-25-064522 3 1 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0000950170-25-064522 3 2 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0000950170-25-064522 3 3 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0000950170-25-064522 3 4 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0000950170-25-064522 4 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Net service revenues 0
0000950170-25-064522 4 2 IS 0 H Cost Of Goods And Services Sold us-gaap/2024 Cost of service revenues 0
0000950170-25-064522 4 3 IS 0 H Gross Profit us-gaap/2024 Gross profit 0
0000950170-25-064522 4 4 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative expenses 0
0000950170-25-064522 4 5 IS 0 H Depreciation And Amortization us-gaap/2024 Depreciation and amortization 0
0000950170-25-064522 4 6 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0000950170-25-064522 4 7 IS 0 H Operating Income Loss us-gaap/2024 Operating income 0
0000950170-25-064522 4 8 IS 0 H Investment Income Interest us-gaap/2024 Interest income 1
0000950170-25-064522 4 9 IS 0 H Interest Expense Debt us-gaap/2024 Interest expense 0
0000950170-25-064522 4 10 IS 0 H Interest Income Expense Nonoperating Net us-gaap/2024 Total interest expense, net 1
0000950170-25-064522 4 11 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Income before income taxes 0
0000950170-25-064522 4 12 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax expense 0
0000950170-25-064522 4 13 IS 0 H Net Income Loss us-gaap/2024 Net income 0
0000950170-25-064522 4 15 IS 0 H Earnings Per Share Basic us-gaap/2024 Basic income per share 0
0000950170-25-064522 4 16 IS 0 H Earnings Per Share Diluted us-gaap/2024 Diluted income per share 0
0000950170-25-064522 4 18 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Basic 0
0000950170-25-064522 4 19 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Diluted 0
0000950170-25-064522 5 8 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0000950170-25-064522 5 9 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0000950170-25-064522 5 10 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 Issuance of shares of common stock under restricted stock award agreements, shares 0
0000950170-25-064522 5 11 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Forfeited us-gaap/2024 Forfeiture of shares of common stock under restricted stock award agreements, shares 1
0000950170-25-064522 5 12 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation 0
0000950170-25-064522 5 13 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2024 Shares issued for exercise of stock options 0
0000950170-25-064522 5 14 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 Shares issued for exercise of stock options, shares 0
0000950170-25-064522 5 15 EQ 0 H Net Income Loss us-gaap/2024 Net Income (Loss) 0
0000950170-25-064522 5 16 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0000950170-25-064522 5 17 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0000950170-25-064522 6 2 CF 0 H Profit Loss us-gaap/2024 Net income 0
0000950170-25-064522 6 4 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0000950170-25-064522 6 5 CF 0 H Deferred Income Tax Expense Benefit us-gaap/2024 Deferred income taxes 0
0000950170-25-064522 6 6 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation 0
0000950170-25-064522 6 7 CF 0 H Amortization Of Financing Costs us-gaap/2024 Amortization of debt issuance costs under the credit facility 0
0000950170-25-064522 6 8 CF 0 H Provision For Doubtful Accounts us-gaap/2024 Provision for credit losses 0
0000950170-25-064522 6 9 CF 0 H Gain Loss On Disposition Of Assets us-gaap/2024 Gain on disposal of assets 1
0000950170-25-064522 6 10 CF 0 H Gain Loss On Termination Of Lease us-gaap/2024 Loss on termination of operating leases 1
0000950170-25-064522 6 12 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable 1
0000950170-25-064522 6 13 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0000950170-25-064522 6 14 CF 0 H Increase Decrease In Government Stimulus Advances 0000950170-25-064522 Government stimulus advances 0
0000950170-25-064522 6 15 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0000950170-25-064522 6 16 CF 0 H Increase Decrease In Employee Related Liabilities us-gaap/2024 Accrued payroll 0
0000950170-25-064522 6 17 CF 0 H Increase Decrease In Other Accounts Payable And Accrued Liabilities us-gaap/2024 Accrued expenses and other long-term liabilities 0
0000950170-25-064522 6 18 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash provided by operating activities 0
0000950170-25-064522 6 20 CF 0 H Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2024 Acquisitions of businesses, net of cash acquired 1
0000950170-25-064522 6 21 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property and equipment 1
0000950170-25-064522 6 22 CF 0 H Proceeds From Sale Of Machinery And Equipment us-gaap/2024 Proceeds received from disposal of assets 0
0000950170-25-064522 6 23 CF 0 H Proceeds From Divestiture Of Businesses us-gaap/2024 Proceeds received from divestiture of business 0
0000950170-25-064522 6 24 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0000950170-25-064522 6 26 CF 0 H Repayments Of Lines Of Credit us-gaap/2024 Payments on revolver - credit facility 1
0000950170-25-064522 6 27 CF 0 H Payments Of Debt Issuance Costs us-gaap/2024 Payments for debt issuance costs under the credit facility 1
0000950170-25-064522 6 28 CF 0 H Proceeds From Stock Options Exercised us-gaap/2024 Cash received from exercise of stock options 0
0000950170-25-064522 6 29 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash used in financing activities 0
0000950170-25-064522 6 30 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net change in cash 0
0000950170-25-064522 6 31 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, at beginning of period 0
0000950170-25-064522 6 32 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash, at end of period 0
0000950170-25-064522 6 34 CF 0 H Interest Paid Net us-gaap/2024 Cash paid for interest 0
0000950170-25-064522 6 35 CF 0 H Income Taxes Paid Net us-gaap/2024 Cash paid (refunded) for income taxes 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.